Canalicular tumors of the salivary glands have recently emerged as an entity characterized by distinct morphology and recurrent HMGA2 gene rearrangement. In this study, we analyzed 40 cases intending to elucidate their features further. The monophasic or biphasic tumors exhibited a growth pattern of interconnected anastomosing trabeculae and canaliculi, accompanied by a classical pleomorphic adenoma in one-third of the cases. Invasive growth into surrounding adipose tissue was revealed in one case which was, therefore, diagnosed as epithelial-myoepithelial carcinoma. Although the tumor cells uniformly expressed HMGA2 protein in all cases, cytokeratin 7, S100 protein, and SOX10 displayed either diffuse positivity or highlighted the luminal and abluminal cell populations, respectively. Areas with morphological oncocytoid change and AR-immunopositivity of luminal cells were seen in 13/14 (93%) of tested biphasic cases. HMGA2 rearrangement was detected by RNA-sequencing in 30 cases. The most common alteration was an HMGA1::WIF1 fusion, but several novel or rare fusion partners were identified, including ARID2 , FHIT , MSRB3 and its antisense variant MSRB3-AS1 , IFNG-AS1 , and the long intergenic region LINC02389 . In addition, FISH revealed HGMA2 break-apart in the remaining 10 cases where targeted sequencing failed to detect any alteration or where RNA sequencing could not be performed. Notably, the loss of the 3'-untranslated region of HMGA2 emerges as the common denominator for the described rearrangements, possibly disrupting its negative regulation by small regulatory RNAs. Awareness of this lesion ensures appropriate diagnosis and clinical management, especially with regard to the possibility of malignant transformation described in this and previous studies.

Anatomic Pathology and Cytopathology Unit Istituto Nazionale Tumori IRCCS Fondazione 'G Pascale' Via Mariano Semmola Naples Italy

Biomedical Center Faculty of Medicine in Pilsen Charles University Czech Republic

Bioptical Laboratory Ltd Pilsen Czech Republic

Department of Anatomical Pathology Canterbury District Health Board Christchurch Hospital Christchurch New Zealand

Department of Pathology School for Oncology and Reproduction Maastricht University Medical Center Maastricht The Netherlands

Department of Pathology University Hospital and Faculty of Medicine in Pilsen Charles University Czech Republic

Department of Pathology University Hospital of Montpellier Montpellier France

Faculdade de Medicina Instituto de Anatomia Patológica Universidade de Lisboa Lisbon Portugal

Institute of Biomedicine Pathology University of Turku and Department of Pathology Turku University Hospital Turku Finland

REFCORpath France

Serviço de Anatomia Patológica Instituto Português de Oncologia de Lisboa Portugal

Zobrazit více v PubMed

Agaimy A, Ihrler S, Baneckova M, et al. . HMGA2-WIF1 rearrangements characterize a distinctive subset of salivary pleomorphic adenomas with prominent trabecular (canalicular adenoma-like) morphology. Am J Surg Pathol. 2022;46:190–199. PubMed

Katabi N, Sukhadia P, DiNapoli SE, et al. . Expanding the histological spectrum of salivary gland neoplasms with HMGA2::WIF1 fusion emphasising their malignant potential: a report of eight cases. Histopathology. 2024;84:387–398. PubMed PMC

Alsugair Z, Lepine C, Descotes F, et al. . Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights. Hum Pathol. 2024;152:105633. PubMed

Alsugair Z, Fieux M, Descotes F, et al. . Peculiar nuclear atypia associated with MDM2 gene amplification in carcinoma ex-pleomorphic adenoma harbouring an alteration of HMGA2. Histopathology. 2024;85:338–346. PubMed

Steiner P, Andreasen S, Grossmann P, et al. . Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands. Virchows Arch. 2018;473:471–480. PubMed

Santana T, Pavel A, Martinek P, et al. . Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Hum Pathol. 2019;93:37–47. PubMed

Landrum MJ, Lee JM, Benson M, et al. . ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067. PubMed PMC

Koboldt DC. Best practices for variant calling in clinical sequencing. Genome Med. 2020;12:91. PubMed PMC

Geurts JM, Schoenmakers EF, Röijer E, et al. . Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res. 1997;57:13–17. PubMed

Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025–1030. PubMed PMC

Borrmann L, Wilkening S, Bullerdiek J. The expression of HMGA genes is regulated by their 3’UTR. Oncogene. 2001;20:4537–4541. PubMed